in this issue
World News and Views :: Top of the News
Merck Serono appoints head of R&D
7:04 AM MDT | July 15, 2014 | Natasha Alperowicz
Merck Serono, the biopharmaceutical division of Merck KGaA, has announced the appointment of Luciano Rossetti as executive v.p. and head/R&D as of 21 July. In his most recent role, Rossetti acted as senior v.p./late-stage development at Merck Sharp & Dohme (MSD). He was responsible for the clinical development from phase two to phase five across all therapeutic areas. At MSD, he played a key role in shaping and implementing the development strategy of several potential breakthrough compounds, such as anti PD-1. He also restructured the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee